Partnership Between PacBio and EpiCypher in Epigenomics
PacBio, known for its innovative sequencing solutions (NASDAQ: PACB), has taken significant strides in the world of genomics. Together with EpiCypher, a leader in epigenetics tools, they've launched a partnership designed to delve deeper into the complexities of chromatin biology. At the heart of this collaboration is the introduction of EpiCypher's CUTANA Hia5 enzyme, which is now available for use with PacBio's Fiber-seq assays.
About Fiber-seq Technology
Fiber-seq is not your typical genomics assay. This advanced method, known as single-molecule chromatin fiber sequencing, is a pioneering whole-genome sequencing (WGS) approach. It captures indispensable aspects of chromatin, like accessibility, DNA methylation, and genetic variation, at an individual DNA molecule level. Unlike traditional short-read approaches, Fiber-seq utilizes PacBio's HiFi sequencing, allowing researchers to uncover connections between multiple genetic and epigenetic attributes in a unified analysis.
Benefits of the PacBio and EpiCypher Collaboration
With EpiCypher's Hia5 enzyme integrated into the Fiber-seq workflow, researchers now have access to a toolkit that enables them to:
Investigate DNA Regulation at the Molecular Level
This technology allows for an unparalleled exploration of DNA regulation, letting researchers pick apart gene regulation complexities by directly associating genetic variations with regulatory mechanisms.
Study Complex Genomic Regions
The Fiber-seq method excels at providing insights into complicated areas of the genome that traditional short-read methods struggle to address. This includes sequences that could be integral to understanding rare diseases and various genetic conditions.
Optimize Research Efficiency
Researchers can now combine multiple assays into one workflow, significantly enhancing their efficiency. This integration not only saves valuable time and resources but also enriches the data gathered, providing a more comprehensive understanding of gene regulation.
Commentary from Leadership
David Miller, VP of Global Marketing at PacBio, expressed excitement about the partnership, emphasizing that “Fiber-seq offers exceptional insights into genome regulation, illuminating mechanisms behind rare diseases and facilitating new discoveries.”
Martis Cowles, the Chief Business Officer at EpiCypher, added, “We are excited to make our CUTANA Hia5 enzyme available for Fiber-seq assays to a broader research community. Together with PacBio, we are unlocking the potential for significant biological breakthroughs.”
Availability and Product Details
The CUTANA Hia5 enzyme can now be obtained through EpiCypher in both 8 and 24 reaction formats, along with a comprehensive Fiber-seq protocol. This enhancing addition to the PacBio systems underscores their commitment to making cutting-edge genomics tools accessible for deeper research.
About PacBio
PacBio stands out as a premier life science technology entity, focused on the design, development, and manufacturing of advanced sequencing solutions. Their HiFi long-read sequencing technology addresses complex genetic issues across diverse applications, from human germline sequencing to infectious disease and oncology.
Frequently Asked Questions
What is the main aim of the PacBio and EpiCypher partnership?
The partnership aims to enhance epigenomics research through the integration of EpiCypher's CUTANA Hia5 enzyme with PacBio's Fiber-seq technology.
What unique capabilities does Fiber-seq provide?
Fiber-seq provides researchers with the ability to analyze chromatin accessibility, DNA methylation, and genetic variation in individual DNA molecules, unlike traditional methods.
How does Fiber-seq improve the efficiency of genomic research?
By consolidating multiple assays into a single workflow, Fiber-seq streamlines the research process, saving both time and resources while producing more comprehensive data.
Can you explain the significance of the Hia5 enzyme?
The Hia5 enzyme is crucial for enhancing the Fiber-seq assay, enabling researchers to generate insights into genome regulation at a single-molecule level.
Who can benefit from the products developed by this partnership?
Researchers in various fields such as biology, agriculture, and medicine can benefit from the advancements in epigenomics offered through the PacBio and EpiCypher partnership.
